Abstract
We examined incidence, prevalence, and correlates of HIV infection in Aboriginal peoples in Canada and found that among most risk groups both Aboriginal and non-Aboriginal participants showed similar levels of HIV prevalence. Aboriginal peoples who use illicit drugs were found to have higher HIV incidence and prevalence when compared to their non-Aboriginal drug-using peers. Aboriginal street youth and female sex workers were also found to have higher HIV prevalence. Among Aboriginal populations, correlates of HIV-positive sero-status include syringe sharing and frequently injecting drugs, as well as geographic and social factors such as living in Vancouver or having a history of non-consensual sex. This study is relevant to Canada and elsewhere, as Indigenous populations are disproportionately represented in the HIV epidemic worldwide.
Similar content being viewed by others
References
Health Canada. HIV and AIDS in Canada. Surveillance report to June 30, 2002. Ottawa: Health Canada; 2002.
Public Health Agency of Canada. Summary: estimates of HIV prevalence and incidence in Canada, 2008. Ottawa: Health Canada; 2008.
Health Canada. First Nations and Inuit Health, 2006. Ottawa: Health Canada; 2006.
Public Health Agency of Canada. HIV/AIDS among Aboriginal persons in Canada: a continuing concern. In: HIV/AIDS epi updates, November 2007. Ottawa: Health Canada; 2007.
Public Health Agency of Canada. HIV/AIDS epi updates, November 2007. Ottawa: Public Health Agency of Canada; 2007.
Health Canada. Understanding the HIV/AIDS epidemic among Aboriginal peoples in Canada: the community at a glance. Ottawa: Health Canada; 2004.
De P, Singh AE, Wong T, Kaida A. Predictors of gonorrhea reinfection in a cohort of sexually transmitted disease patients in Alberta, Canada, 1991–2003. Sex Transm Dis. 2007;34:30–6.
Romanowski B, Preiksaitis J, Campbell P, Fenton J. Hepatitis C seroprevalence and risk behaviours in patients attending sexually transmitted disease clinics. Sex Transm Dis. 2003;30:33–8.
Shields SA, Wong T, Mann J, et al. Prevalence and correlates of chlamydia infection in Canadian street youth. J Adolesc Health. 2004;34(5):384–90.
Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999;354(9193):1896–900.
Public Health Agency of Canada. Inventory of HIV incidence and prevalence studies in Canada, August 2006. Ottawa: Public Health Agency of Canada; 2006.
Pagano M, Gauvreau K. Principles of biostatistics. 2nd ed. Pacific Grove, CA: Duxbury; 2000.
Clopper CJ, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika. 1934;26(4):404–13.
Strathdee SA, Patrick DM, Currie SL, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997;11(8):F59–65.
Schecter M, Heath K, Strathdee SA, Palepu A, O’Shaughnessy MV. Determinants of HIV infection in a cohort of native Canadian injection drug users. In: XIIth international AIDS conference, June 28–July 3, 1998, Geneva, Switzerland (abstract).
Miller CL, Tyndall M, Li K, Laliberte N, Spittal P, Schechter M. High rates of HIV positivity among young injection drug users. Can J Infect Dis. 2001;12(suppl B):340 (abstract).
Miller CL, Spittal P, Laliberte N, et al. Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection among youth who use injection drugs. J Acquir Immune Defic Syndr. 2002;30(3):335–41.
Spittal PM, Craib KJP, Wood E, et al. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. Can Med Assoc J. 2002;166(7):894–9.
Craib KJP, Spittal PM, Wood E, et al. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. Can Med Assoc J. 2003;168(1):19–24.
Tyndall MW, Currie S, Spittal P, et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS. 2003;17(6):887–93.
O’Connell JM, Kerr T, Li K, et al. Requiring help injecting independently predicts incident HIV infection among injection drug users. J Acquir Immune Defic Syndr. 2005;40(1):83–8.
Spittal PM, Craib KJ, Schechter MT, Medd L, Barney L, Baylis C. HIV and HCV prevalence and risk factors among young Aboriginal drug users in Vancouver and Prince George, British Columbia. Can J Infect Dis Med Microbiol. 2005;16(suppl A):191 (abstract).
Corneil TA, Kuyper LM, Shoveller J, et al. Unstable housing, associated risk behaviour, and increased risk for HIV infection among injection drug users. Health Place. 2006;12(1):79–85.
Craib KJP, Moniruzzaman A, Schechter MT, Spittal PM. HIV and HCV prevalence and risk factors among Aboriginal youth that use injection drugs. Can J Infect Dis Med Microbiol. 2006;17(suppl A):356 (abstract).
Miller CL, Strathdee SA, Spittal PM et al. Elevated rates of HIV infection among young Aboriginal injection drug users in a Canadian setting. Harm Reduct J. 2006;3:9.
Tyndall MW, Wood E, Zhang R, Lai C, Montaner JSG, Kerr T. HIV seroprevalence among participants at a supervised injection facility in Vancouver, Canada: implications for prevention, care and treatment. Harm Reduct J. 2006;3:36.
Maas B, Fairbairn N, Kerr T, Li K, Montaner JSG, Wood E. Neighborhood and HIV infection among IDU: place of residence independently predicts HIV infection among a cohort of injection drug users. Health Place. 2007;13(2):432–9.
Spittal PM, Craib KJP, Tegee M, et al. The Cedar Project: prevalence and correlates of HIV infection among young Aboriginal people who use drugs in two Canadian cities. Int J Circumpolar Health. 2007;66(3):226–40.
Wood E, Lloyd-Smith E, Li K, et al. Frequent needle exchange use and HIV incidence in Vancouver, Canada. Am J Med. 2007;120(2):172–9.
Marshall BDL, Kerr T, Livingstone C, Li K, Montaner JSG, Wood E. High prevalence of HIV infection among homeless and street-involved Aboriginal youth in a Canadian setting. Harm Reduct J. 2008;5:35.
Mehrabadi A, Craib KJP, Patterson K, et al. The Cedar Project: a comparison of HIV-related vulnerabilities amongst young Aboriginal women surviving drug use and sex work in two Canadian cities. Int J Drug Policy. 2008;19(2):159–68.
Mehrabadi A, Paterson K, Pearce M, et al. Gender differences in HIV and hepatitis C related vulnerabilities among Aboriginal young people who use street drugs in two Canadian cities. Women Health. 2008;48(3):235–60.
Pearce ME, Christian WM, Patterson K, et al. The Cedar Project: historical trauma, sexual abuse and HIV risk among young Aboriginal people who use injection and non-injection drugs in two Canadian cities. Soc Sci Med. 2008;66(11):2185–94.
Pearce ME, Christian WM, Patel SH, et al. The Cedar Project: experience of foster care and HIV risk among young Aboriginal people who use injection and non-injection drugs in two Canadian cities. Can J Infect Dis Med Microbiol. 2008;19(suppl A):262 (abstract).
Schechter MT, Craib KJ, Clement K, et al. The Cedar Project: factors associated with HIV seroconversion among Aboriginal people who use injection and non-injection drugs in Vancouver and Prince George, British Columbia. Can J Infect Dis Med Microbiol. 2008;19(suppl A):266 (abstract).
Wood E, Montaner JSG, Li K, et al. Burden of HIV infection among Aboriginal injection drug users in Vancouver, British Columbia. Am J Public Health. 2008;98(3):515–9.
DeBeck K, Kerr T, Li K, et al. Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs. Can Med Assoc J. 2009;181(9):585–9.
Rothon DA, Mathias RG, Schechter MT. Prevalence of HIV infection in provincial prisons in British Columbia. Can Med Assoc J. 1994;151(6):781–7.
Buxton JA, Rothon D, Durigon M, et al. Hepatitis C and HIV prevalence using oral mucosal transudate, and reported drug use and sexual behaviours of youth in custody on British Columbia. Can J Public Health. 2009;100(2):121–4.
Martin JD, Mathias RG, Sarin C, Byrne SE. HIV and hepatitis B surveillance in First Nations alcohol and drug treatment centres in British Columbia, Canada, 1992–2000. Int J Circumpolar Health. 2002;61(2):104–9.
Callaghan RC, Cull R, Vettese LC, Taylor L. A gendered analysis of Canadian Aboriginal individuals admitted to inpatient substance abuse detoxification: a three-year medical chart review. Am J Addict. 2006;15(5):380–6.
Heath KV, Cornelisse PGA, Strathdee SA, et al. HIV-associated risk factors among young Canadian Aboriginal and non-Aboriginal men who have sex with men. Int J STD AIDS. 1999;10(9):582–7.
Ogilvie GS. Trends in care for HIV positive pregnant women in British Columbia, 1994–1999. Vancouver: University of British Columbia; 2001 (thesis).
Money D, van Schalkwyk J, Maan E, et al. Perinatal outcomes in a cohort of ART treated HIV positive pregnant women in British Columbia. Can J Infect Dis Med Microbiol. 2007;18(suppl B):31 (abstract).
Rekart ML, Chan S, Barnett J, Lawrence C, Manzon L. HIV and North American Aboriginal peoples. In: VIIth international AIDS conference, June 16–21, 1991, Florence, Italy (abstract).
Hogg RS, Strathdee S, Kerr T, Wood E, Remis R. HIV prevalence among Aboriginal British Columbians. Harm Reduct J. 2005;2:26.
Shannon K, Bright V, Gibson K, Tyndall MW, the MAKA Project Partnership. Sexual and drug-related vulnerabilities for HIV infection among women engaged in survival sex work in Vancouver, Canada. Can J Public Health. 2007;98(6):465–9.
Calzavara L, Ramuscak N, Burchell AN, et al. Prevalence of HIV and hepatitis C virus infections among inmates of Ontario remand facilities. Can Med Assoc J. 2007;177(3):257–61.
Liu J, Remis RS, Myers T, Husbands W, Ogunnaike-Cooke S, Archibald CP. Ethno-racial variation in sexual behaviour and HIV infection among men who have sex with men (MSM): results from the Lambda study. Can J Infect Dis Med Microbiol. 2010;21(suppl B):22 (abstract).
Linton AB, Singh MD, Turbow D, Legg TJ. Street youth in Toronto, Canada: an investigation of demographic predictors of HIV status among street youth who access preventive health and social services. J HIV AIDS Soc Serv. 2009;8(4):375–96.
Romanowski B, Campbell PJ, Preiksaitis JK, Fonseca K. Human immunodeficiency virus seroprevalence and risk behaviours in patients attending sexually transmitted disease clinics in Alberta. Sex Transm Dis. 1997;24(8):487–94.
Houston S, Mashinter L, Rowe B, Joffe M, Preiksaitis JK, Jhangri G. An anonymous unlinked seroprevalence study of HIV in urban Canadian Emergency Departments. Can J Infect Dis Med Microbiol. 2010;21(suppl B):62 (abstract).
Wylie JL, Shah L, Jolly AM. Demographic, risk behaviour and personal network variables associated with prevalent hepatitis C, hepatitis B, and HIV infection in injection drug users in Winnipeg, Canada. BMC Public Health. 2006;6:229.
Siushansian J, Archibald CP, Lior LY, et al. Northern exposures: HIV and HCV spread among injection drug users in a small Canadian community. In: XIIIth international AIDS conference, July 9–14, 2000, Durban, South Africa (abstract).
Weber AE, Chan K, George C, et al. Risk factors associated with HIV infection among young gay and bisexual men in Canada. J Acquir Immune Defic Syndr. 2001;28(1):81–8.
Hankins C, Hum L, Tran T, et al. Low HIV prevalence among childbearing women of Aboriginal origin. AIDS. 1997;11(7):945–7.
Mai N, Patrick D, Houston S, et al. HIV among aboriginal people in Canada: injection drug use is a main concern. In: XIIth international AIDS conference, June 28–July 3, 1998, Geneva, Switzerland (abstract).
Forbes J, Alimenti A, Ayers D, et al. Perinatal HIV therapy and vertical transmission in Aboriginal mother-infant pairs living in Canada: data from the Canadian Perinatal HIV Surveillance Program (CPHSP) 1997–2008. Can J Infect Dis Med Microbiol. 2010;21(suppl B):28 (abstract).
Mill JE, Jackson RC, Worthington CA, et al. HIV testing and care in Canadian Aboriginal youth: a community based mixed methods study. BMC Infect Dis. 2008;8:132–45.
McInnes CW, Druyts E, Harvard SS, et al. HIV/AIDS in Vancouver, British Columbia: a growing epidemic. Harm Reduct J. 2009;6:5.
Druyts EF, Rachlis BS, Lima VD, et al. Mortality is influenced by locality in a major HIV/AIDS epidemic. HIV Med. 2009;10(5):274–81.
Joy R, Druyts EF, Brandson EK, et al. Impact of neighborhood-level socioeconomic status on HIV disease progression in a universal health care setting. J Acquir Immune Defic Syndr. 2008;47(4):500–5.
Larkin J, Flicker S, Koleszar-Green R, Mintz S. HIV risk, systemic inequities, and Aboriginal youth: widening the circle for HIV prevention programming. Can J Public Health. 2007;98(3):179–82.
Sinha MM. Sex, structural violence, and AIDS: case studies of Indian prostitutes. Women’s Stud Q. 1999;27(1/2):65–72.
Waldram JB, Herring DA, Young TK. Aboriginal health in Canada: historical, cultural, and epidemiological perspectives. Toronto: University of Toronto Press; 1995.
Canada Mortgage and Housing Corporation. 2001 census housing series issue 6: revised Aboriginal households. Canada: CMHC; 2001.
Fenton L. Preventing AIDS through poverty reduction: the only sustainable solution? Lancet. 2004;364(9440):1186–7.
Shelton JD, Cassel MM, Adetunji J. Is poverty or wealth the root of HIV? Lancet. 2005;366(9491):1057–8.
Stillwaggon E. HIV/AIDS in Africa: fertile terrain. J Dev Stud. 2002;38(6):1–22.
Larkin JA. Women, poverty and HIV infection. Can Womens Stud. 2000;20(3):137–41.
Des Jarlais DC, Semaan S. HIV prevention for injecting drug users: the first 25 years and counting. Psychosom Med. 2008;70(5):606–11.
Oetzel J, Duran B. Intimate partner violence in American Indian and/or Alaska native communities: a social ecological framework of determinants and interventions. Am Indian Alsk Native Ment Health Res. 2004;11(3):49–68.
Acknowledgments
RSH and VL conceived and designed this review. KCD, AMB, MCM and WM analysed and interpreted the data. KCD, AMB, and MCM drafted the manuscript. RSH, JSGM, VL, AP, WM and CR critically revised the manuscript for content. All authors saw and approved the final manuscript. We are grateful to the Cedar Project Partnership, Eirikka Brandson, Steve Kanters, and Nadia O’Brien for their help with data acquisition, data quality and content editing. We thank the Canadian Institutes of Health Research (CIHR) for its continuing support. KCD thanks the CIHR Translational Research in Infectious Disease grant for its support. VDL acknowledges the Michael Smith Foundation in Health Research and the CIHR for two fellowships. JSGM is supported by the Ministry of Health Services and the Ministry of Healthy Living and Sport, from the Province of British Columbia; through a Knowledge Translation Award from the CIHR; and through an Avant-Garde Award (No. 1DP1DA026182-01) from the National Institute of Drug Abuse, at the US National Institutes of Health. He also received funding from Merck, Gilead and ViiV to support research into Treatment as Prevention.
Conflict of Interest
KCD, CR, AMB, MCM, AP, WM, HS, VDL, JSGM, and RSH declare they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Duncan, K.C., Reading, C., Borwein, A.M. et al. HIV Incidence and Prevalence Among Aboriginal Peoples in Canada. AIDS Behav 15, 214–227 (2011). https://doi.org/10.1007/s10461-010-9792-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-010-9792-y